Shedir Pharma Srl Unipersonale
MIL:SHE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Diamond Hill Investment Group Inc
NASDAQ:DHIL
|
US |
Shedir Pharma Srl Unipersonale
Cash from Operating Activities
Shedir Pharma Srl Unipersonale
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Shedir Pharma Srl Unipersonale
MIL:SHE
|
Cash from Operating Activities
€599k
|
CAGR 3-Years
-61%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Newron Pharmaceuticals SpA
SIX:NWRN
|
Cash from Operating Activities
€32.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
|
Cash from Operating Activities
€596.9m
|
CAGR 3-Years
9%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
Shedir Pharma Srl Unipersonale
Glance View
Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.
See Also
What is Shedir Pharma Srl Unipersonale's Cash from Operating Activities?
Cash from Operating Activities
599k
EUR
Based on the financial report for Dec 31, 2023, Shedir Pharma Srl Unipersonale's Cash from Operating Activities amounts to 599k EUR.
What is Shedir Pharma Srl Unipersonale's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 3Y
-61%
Over the last year, the Cash from Operating Activities growth was -76%. The average annual Cash from Operating Activities growth rates for Shedir Pharma Srl Unipersonale have been -61% over the past three years .
